Is Tvardi Therapeutics a good buy right now?
USNASDAQ: TVRDNASDAQ-listedlast $3.08 · 8 Jul 2026
Not yet — wait
Signal paused. TVRD's price history has a jump — most likely a split or bonus issue that was not adjusted — and 4 trades touching it were left out until the data is checked. The last Buy signal came on 8 Jul 2026 at $5.66 and closed on 8 Jul 2026 (−45.6%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 12 buy signals on TVRD
Oct 2024 – 30 Sep 20261 of 12 closed above the entry price, with an average outcome of −15.1% per signal before costs; a signal typically stayed open about 2 d. 4 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 8 Jul 2026 | $5.66 | 8 Jul 2026 | 1 d | -45.6% |
| 28 Apr 2025 | $20.22 | 21 May 2025 | 3 wk | +65.9% |
| 23 Apr 2025 | $19.31 | 25 Apr 2025 | 2 d | -11.9% |
| 22 Apr 2025 | $20.9 | 22 Apr 2025 | 1 d | -16.3% |
| 16 Apr 2025 | $19.52 | 17 Apr 2025 | 1 d | -14.2% |
| 24 Jan 2025 | $17.34 | 28 Jan 2025 | 4 d | -13.5% |
| 6 Jan 2025 | $16.17 | 10 Jan 2025 | 4 d | -16.3% |
| 2 Jan 2025 | $17.19 | 6 Jan 2025 | 4 d | -10.3% |
| 31 Dec 2024 | $18.57 | 31 Dec 2024 | 1 d | -30.6% |
| 23 Dec 2024 | $15.48 | 27 Dec 2024 | 4 d | -16.3% |
| 20 Dec 2024 | $16.47 | 20 Dec 2024 | 1 d | -23.6% |
| 19 Dec 2024 | $17.91 | 19 Dec 2024 | 1 d | -48.2% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 8% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about TVRD
TVRD share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Tvardi Therapeutics. Signal paused. TVRD's price history has a jump — most likely a split or bonus issue that was not adjusted — and 4 trades touching it were left out until the data is checked. The last Buy signal came on 8 Jul 2026 at $5.66 and closed on 8 Jul 2026 (−45.6%). The last price on record was $3.08 on 8 Jul 2026.
How has Firefly's strategy done on Tvardi Therapeutics?
From October 2024 to 30 Sep 2026 Firefly's rules gave 12 buy signals on Tvardi Therapeutics; 1 closed above the entry price and the average outcome was −15.1% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Tvardi Therapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Tvardi Therapeutics and how it turned out is listed on this page.
Should I sell Tvardi Therapeutics?
No sell trigger is active on Tvardi Therapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →